These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 28418878

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Increased lung cancer risk associated with the TERT rs2736100 polymorphism: an updated meta-analysis.
    Yang J, Jiao S.
    Tumour Biol; 2014 Jun; 35(6):5763-9. PubMed ID: 24590268
    [Abstract] [Full Text] [Related]

  • 23. Association between the telomerase reverse transcriptase (TERT) rs2736098 polymorphism and cancer risk: evidence from a case-control study of non-small-cell lung cancer and a meta-analysis.
    Wu H, Qiao N, Wang Y, Jiang M, Wang S, Wang C, Hu L.
    PLoS One; 2013 Jun; 8(11):e76372. PubMed ID: 24260099
    [Abstract] [Full Text] [Related]

  • 24. TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations.
    Dahlström J, Liu T, Yuan X, Saft L, Ghaderi M, Wei YB, Lavebratt C, Li P, Zheng C, Björkholm M, Xu D.
    Ann Hematol; 2016 Oct; 95(11):1825-32. PubMed ID: 27561898
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. TERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls.
    Nie W, Zang Y, Chen J, Xiu Q.
    Tumour Biol; 2014 Jun; 35(6):5569-74. PubMed ID: 24535778
    [Abstract] [Full Text] [Related]

  • 27. New evidence of TERT rs2736098 polymorphism and cancer risk: an updated meta-analysis.
    Li T, Xian Y, Tian T, Zhuang X, Chu M.
    J BUON; 2016 Jun; 21(2):491-7. PubMed ID: 27273963
    [Abstract] [Full Text] [Related]

  • 28. Association of telomerase reverse transcriptase gene rs10069690 variant with cancer risk: an updated meta-analysis.
    Zhou C, Yang Y, Shen L, Wang L, Zhang J, Wu X.
    BMC Cancer; 2024 Aug 27; 24(1):1059. PubMed ID: 39192222
    [Abstract] [Full Text] [Related]

  • 29. Associations of telomerase reverse transcriptase rs10069690 and rs2736100 polymorphisms with papillary thyroid carcinoma.
    Liu Y, Shi F.
    Eur J Cancer Prev; 2020 May 27; 29(3):259-265. PubMed ID: 31651569
    [Abstract] [Full Text] [Related]

  • 30. Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A meta-analysis.
    Li ZY, Dong YL, Feng Y, Zhang Z, Cao XZ.
    J Cancer Res Ther; 2016 May 27; 12(2):1040-4. PubMed ID: 27461695
    [Abstract] [Full Text] [Related]

  • 31. Genetic variants in telomerase reverse transcriptase (TERT) and telomerase-associated protein 1 (TEP1) and the risk of male infertility.
    Yan L, Wu S, Zhang S, Ji G, Gu A.
    Gene; 2014 Jan 25; 534(2):139-43. PubMed ID: 24269974
    [Abstract] [Full Text] [Related]

  • 32. Association of genetic polymorphisms in the telomerase reverse transcriptase gene with prostate cancer aggressiveness.
    Wu D, Yu H, Sun J, Qi J, Liu Q, Li R, Zheng SL, Xu J, Kang J.
    Mol Med Rep; 2015 Jul 25; 12(1):489-97. PubMed ID: 25738283
    [Abstract] [Full Text] [Related]

  • 33. Telomerase Reverse Transcriptase (TERT) Gene Variations and Susceptibility of Colorectal Cancer.
    Jannuzzi AT, Karaman E, Oztas E, Yanar HT, Özhan G.
    Genet Test Mol Biomarkers; 2015 Dec 25; 19(12):692-7. PubMed ID: 26501986
    [Abstract] [Full Text] [Related]

  • 34. Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis.
    Yan Y, Liang H, Xie L, He Y, Li M, Li R, Li S, Qin X.
    Tumour Biol; 2014 Mar 25; 35(3):2191-7. PubMed ID: 24142546
    [Abstract] [Full Text] [Related]

  • 35. Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.
    Mosrati MA, Willander K, Falk IJ, Hermanson M, Höglund M, Stockelberg D, Wei Y, Lotfi K, Söderkvist P.
    Oncotarget; 2015 Sep 22; 6(28):25109-20. PubMed ID: 26298771
    [Abstract] [Full Text] [Related]

  • 36. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y, Zhang L, Yang Q, Li B, Guo L, Fang C, Gao C, Wang J, Xiang J, Li J.
    Cerebrovasc Dis; 2012 Sep 22; 33(6):558-65. PubMed ID: 22688093
    [Abstract] [Full Text] [Related]

  • 37. TERT polymorphisms modify the risk of acute lymphoblastic leukemia in Chinese children.
    Sheng X, Tong N, Tao G, Luo D, Wang M, Fang Y, Li J, Xu M, Zhang Z, Wu D.
    Carcinogenesis; 2013 Jan 22; 34(1):228-35. PubMed ID: 23066086
    [Abstract] [Full Text] [Related]

  • 38. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C, Hou WH, Ding XX, Wang X, Zhao H, Han XW, Wang WJ.
    Asian Pac J Cancer Prev; 2016 Jan 22; 17(8):3785-91. PubMed ID: 27644617
    [Abstract] [Full Text] [Related]

  • 39. The TERT MNS16A polymorphism contributes to cancer susceptibility: meta-analysis of the current studies.
    Chen P, Zou P, Yan Q, Xu H, Zhao P, Gu A.
    Gene; 2013 May 01; 519(2):266-70. PubMed ID: 23462332
    [Abstract] [Full Text] [Related]

  • 40. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
    Kong Q, Li P, Tian Q, Ha MW.
    Genet Test Mol Biomarkers; 2014 May 01; 18(5):357-65. PubMed ID: 24673452
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.